A South Korean panel of experts said Tuesday that vaccines for the novel coronavirus by US pharmaceutical company Pfizer Inc showed a more than 95 per cent efficacy rate, and the use of the vaccine is not problematic for young people. The advisory board consisting of outside experts announced it